Swedbank AB Has $24.01 Million Position in The Clorox Company $CLX

Key Points

• Swedbank AB significantly increased its stake in The Clorox Company by 232.9% in Q1, holding 163,084 shares worth approximately $24 million.
• Multiple institutional investors, including HSBC and KBC Group, have also increased their holdings in Clorox, indicating a growing interest in the company.
• The Clorox Company reported a 4.5% revenue increase year-over-year for its last quarter, achieving earnings per share of $2.87, which exceeded analysts' expectations.

Swedbank AB lifted its holdings in The Clorox Company (NYSE:CLX - Free Report) by 232.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 163,084 shares of the company's stock after acquiring an additional 114,100 shares during the quarter. Swedbank AB owned approximately 0.13% of Clorox worth $24,014,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Hsbc Holdings PLC boosted its stake in Clorox by 118.8% in the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after purchasing an additional 589,544 shares in the last quarter. KBC Group NV lifted its position in Clorox by 688.7% during the 1st quarter. KBC Group NV now owns 587,679 shares of the company's stock worth $86,535,000 after buying an additional 513,171 shares in the last quarter. AQR Capital Management LLC grew its holdings in Clorox by 412.1% during the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company's stock worth $88,167,000 after acquiring an additional 481,846 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Clorox by 147.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company's stock worth $104,107,000 after acquiring an additional 421,453 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Clorox by 11,108.0% in the 1st quarter. GAMMA Investing LLC now owns 349,130 shares of the company's stock valued at $51,409,000 after acquiring an additional 346,015 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research reports. Morgan Stanley reduced their target price on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. JPMorgan Chase & Co. lifted their target price on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a research note on Monday, September 8th. Barclays cut their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. Wells Fargo & Company lowered their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a research report on Friday, September 5th. Finally, UBS Group dropped their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Reduce" and an average price target of $142.18.

Clorox Trading Up 1.6%

Shares of NYSE:CLX traded up $1.97 during midday trading on Tuesday, hitting $124.79. The company had a trading volume of 1,737,307 shares, compared to its average volume of 1,666,903. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market cap of $15.26 billion, a price-to-earnings ratio of 19.14, a PEG ratio of 0.99 and a beta of 0.52. The firm has a fifty day simple moving average of $124.24 and a 200 day simple moving average of $131.91.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. The firm's revenue was up 4.5% on a year-over-year basis. During the same period last year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were issued a dividend of $1.24 per share. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date was Wednesday, August 13th. Clorox's dividend payout ratio is presently 76.07%.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.57% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.